AzTrials
AzTrials

Pain, PostoperativeNCT06436105

Comparison of Fasia Iliac Compartment Block and 4in1 Block

A study testing FICB and 4 in 1 block in people with Pain, Postoperative, run by Diskapi Yildirim Beyazit Education and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Patients who will undergo elective total knee arthroplasty surgery under spinal anesthesia will be included in the study according to the postoperative analgesia method applied: Group Control, Group FICB and Group 4in1. Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Pain, Postoperative
What is being tested?
FICB and 4 in 1 block
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteTurkey (Türkiye)
Study dates
30 May 2024to 8 Jul 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • With informed consent
  • Elective total knee arthroplasty with spinal anesthesia
  • Oriented and cooperative
  • ASA Classification I-II-III
  • 18-85 years old

Who cannot join

  • Anticoagulant medication
  • Coagulopathy
  • Infection at the site of peripheral nerve block application
  • Allergy to local anesthetics
  • Pregnant or suspected pregnancy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Department of Anesthesiology and Reanimation, University of Health Sciences, Diskapi Yıldırım Beyazit Training and Research Hospital

    Ankara, 06450

Other trials in Turkey (Türkiye)

About this study

Official title: Comparison of Perioperative Analgesic Effectiveness of Patients Who Had Fasia Iliac Compartment Block and 4in1 Block Applied in Total Knee Prosthesis Surgery

Patients who will undergo elective total knee arthroplasty surgery under spinal anesthesia will be included in the study according to the postoperative analgesia method applied: Group Control, Group FICB and Group 4in1. Peripheral nerve block will be performed with 30 ml %0.25 bupivacaine for Group FICB and Group 4 in 1 patients. Peripheral nerve block will not be performed on Group Control patients. Patient-controlled analgesia will be given to all three groups in the postoperative period. PCA is a pain palliation method routinely used in all patients postoperatively. NRS score, PCA tramadol consumption, PCA demand, need for additional analgesia, patient satisfaction, nausea and vomiting will be monitored 24 hours postoperatively. The aim of this study is to compare the perioperative analgesic effectiveness of patients who underwent fascia iliaca compartment block and 4 in 1 block in total knee arthroplasty surgery, with each other and with the control group.

Read the detailed description

Total knee arthroplasty is a surgical procedure performed mostly on patients with osteoarthritis who have failed traditional conservative treatment. Increasing knee osteoarthritis due to reasons such as life expectancy and body mass index causes this surgical procedure to be performed more frequently. The knee joint which is innervated by the femoral, obturator, sciatic nerves and their branches has a complicated innervation and the pain following total knee arthrplasty is quite severe. It is aimed to provide effective analgesia by blocking these nerves or terminal branches with various peripheral nerve blockade methods under USG guidance. In recent years, interest in studies aiming to block these nerves with a single injection has been increasing. 4 in 1 block is a new technique applied from a single injection point to block the saphenous, obturator, sciatic and vastus medialis nerves that innervate the knee joint. Fascia iliaca compartment block is a reliable technique applied from a single injection point to block the femoral, lateral femoral cutaneous and obturator nerves behind the fascia iliaca.

Patients who will undergo elective total knee arthroplasty surgery under spinal anesthesia will be included in the study according to the postoperative analgesia method applied: Group Control, Group FICB and Group 4in1. Peripheral nerve block will be performed with 30 ml %0.25 bupivacaine for Group FICB and Group 4 in 1 patients. Peripheral nerve block will not be performed on Group Control patients. Patient-controlled analgesia will be given to all three groups in the postoperative period. PCA is a pain palliation method routinely used in all patients postoperatively. NRS score, PCA tramadol consumption, PCA demand, need for additional analgesia, patient satisfaction, nausea and vomiting will be monitored 24 hours postoperatively. The aim of this study is to compare the perioperative analgesic effectiveness of patients who underwent fascia iliaca compartment block and 4 in 1 block in total knee arthroplasty surgery, with each other and with the control group.

Being tested
FICB, 4 in 1 block, Control
Keywords
FICB, 4 in 1 block, Total knee arthroplasty
Medical subject headings
Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FICBOther

    FICB is applied to the patients after spinal anesthesia.

  • 4 in 1 blockOther

    4 in 1 block is applied to the patients after spinal anesthesia.

  • ControlOther

    Peripheral nerve block will not be performed on Group Control patients.

Study groups in NCT06436105
Study groupRoleWhat they receive
Group ControlOtherPeripheral nerve block will not be performed on Group Control patients.
Receives: Other: Control
Group FICBOtherFICB will be performed with 30 ml %0.25 bupivacaine for Group FICB patients.
Receives: Other: FICB
Group 4 IN 1Other4 in 1 block will be performed with 30 ml %0.25 bupivacaine for Group 4 IN 1 patients.
Receives: Other: 4 in 1 block

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total tramadol consumption in 24 hours (mg)

    Total tramadol consumption used in the first 24 hours postoperatively

    Measured: 24 hours postoperatively

Secondary outcomes (8)
  1. Pain on the Numeric Rating Scale (NRS)

    NRS range was from 0-10 with being no pain and 10 the worst pain possible.

    Measured: 0 hours postoperatively

  2. Pain on the Numeric Rating Scale (NRS)

    NRS range was from 0-10 with being no pain and 10 the worst pain possible.

    Measured: 1 hours postoperatively

  3. Pain on the Numeric Rating Scale (NRS)

    NRS range was from 0-10 with being no pain and 10 the worst pain possible.

    Measured: 4 hours postoperatively

  4. Pain on the Numeric Rating Scale (NRS)

    NRS range was from 0-10 with being no pain and 10 the worst pain possible.

    Measured: 8 hours postoperatively

  5. Pain on the Numeric Rating Scale (NRS)

    NRS range was from 0-10 with being no pain and 10 the worst pain possible.

    Measured: 12 hours postoperatively

  6. Pain on the Numeric Rating Scale (NRS)

    NRS range was from 0-10 with being no pain and 10 the worst pain possible.

    Measured: 24 hours postoperatively

  7. Rescue Analgesic

    Consumption of rescue analgesic used after 24 hours postoperatively.

    Measured: 24 hours postoperatively

  8. Patient satisfaction

    The patient is satisfied or dissatisfied

    Measured: 24 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2024
  2. Study start30 May 2024
  3. Primary completion1 Jul 2024
  4. Study completion8 Jul 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06436105
Sponsor's protocol ID
İsa Öteleş
Status last verified
Jun 2025
First submitted
24 May 2024
Last updated
29 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Roy R, Agarwal G, Pradhan C, Kuanardr D, Mallick DJ. Ultrasound guided 4 in 1 block - a newer, single injection technique for complete postoperative analgesia for knee and below knee surgeries. Anaesthesia, Pain & Intensive Care. 2018;22(1):87-92.

  • Kanadli H, Dogru S, Karaman T, Karaman S, Tapar H, Sahin A, Asci M, Kanadli KA, Suren M. Comparison of the efficacy of femoral nerve block and fascia iliaca compartment block in patients with total knee replacement. Minerva Anestesiol. 2018 Oct;84(10):1134-1141. doi: 10.23736/S0375-9393.18.12062-1. Epub 2018 Jan 16.

    PubMed 29338141

Questions about this trial

What is this clinical trial studying?

A study testing FICB and 4 in 1 block in people with Pain, Postoperative, run by Diskapi Yildirim Beyazit Education and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total tramadol consumption in 24 hours (mg) (time frame: 24 hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06436105, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in